Areas of Focus
- Drug Chemistry
- Drug Synthesis Chemistry
- Drug Discovery and Development
Academic Background & Achievements
- 2005-09 to 2008-06 PhD: Shandong University
- 2002-09 to 2005-06 Master's: Qingdao University of Science and Technology
- 1999-09 to 2002-06 Bachelor's: Liaocheng University
Publications
- Study on structure-activity relationship (SAR) of simplified mirogabalin derivatives as voltage-gated calcium channel α2δ ligands for the treatment of chronic neuropathic pain, Guilong Zhao, 2023
- Review of voltage-gated calcium channel α2δ subunit ligands for the treatment of chronic neuropathic pain and insight into structure-activity relationship (SAR) by pharmacophore modeling, Guilong Zhao, 2022
- Allosteric Inhibitors of SHP2: An Updated Patent Review (2015-2020), Jingwei Wu, Huan Zhang, Guilong Zhao, Runling Wang, 2021
- Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout, Jingwei Wu, Ling Yin, Yuqiang Liu, Huan Zhang, Yafei Xie, Runling Wang, Guilong Zhao, 2019
- Nickel-Catalyzed Amidoalkylation Reaction of gamma-Hydroxy Lactams: An Access to 3-Substituted Isoindolinones, Shuo Zhang, Xinhua Shi, Jichao Li, Zitong Hou, Zihe Song, Xiaofeng Su, Dan Peng, Feng Wang, Yitao Yu, Guilong Zhao, 2019
- Release of Amino- or Carboxy-Containing Compounds Triggered by HOCl: Application for Imaging and Drug Design, Peng Wei, Lingyan Liu, Ying Wen, Guilong Zhao, Fengfeng Xue, Wei Yuan, Ruohan Li, Yaping Zhong, Mengfan Zhang, Tao Yi, 2019
- Systematic Structure-Activity Relationship (SAR) Exploration of Diarylmethane Backbone and Discovery of A Highly Potent Novel Uric Acid Transporter 1 (URAT1) Inhibitor, Wenqing Cai, Jingwei Wu, Wei Liu, Yafei Xie, Yuqiang Liu, Shuo Zhang, Weiren Xu, Lida Tang, Jianwu Wang, Guilong Zhao, 2018